Global Nuclear Imaging Market Research Report
- Report Code: NU 1000
- Publish Date: Upcoming
The Global nuclear medicine devices market is mainly driven by increasing awareness, rising cases of various diseases vis-à-vis the ageing population, and increasing investments, funds, grants by government bodies.
The market was valued at $3.5 billion in 2013 and is expected to reach $5.0 billion by 2018, at a CAGR of 7.0%. The technology segment of global nuclear medicine devices market commanded the largest share of total market.
The report “Nuclear Medicine Devices Market Forecast, 2012-2018” analyzes the market of devices by 2 major segments such as nuclear medicine devices- by technology and by portability. Both the segments experienced positive growth till 2012 due to technological advancements in various nuclear medicine devices and increase in patient pool. Nuclear medicine has been broadly classified into PET and SPECT.
On the basis of technology, the 2D imaging market accounted for the largest share of the global nuclear medicine devices market, in 2013. This large share can be attributed to the high demand for 2D imaging systems in emerging countries. In the global nuclear medicine market-by portability, trolley-based systems held the largest market share in 2013.
Technological advancements and increasing adoption of nuclear medicine systems in emerging markets are the key factors driving this market. However, the compact/portable system market is poised to grow at a faster pace than trolley-based systems in the forecast period, at a CAGR of XX%. This growth can be attributed to the increasing demand for these systems in mature markets, new product launches, and technological modifications by big market players.
Geographically, North America accounted for the largest share in terms of revenue of the total nuclear medicine devices market. This is majorly due to the presence of large number of key players such as GE Healthcare and Siemens Healthcare in the region. Owing to rising geriatric population, it has been projected that Asia-Pacific and Rest of the World (RoW) will grow at the highest and second highest CAGR respectively, during the forecast period. Improving government initiatives will further augment the growth of this market in aforementioned regions.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in this market and extensively covered in this report are GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, Inc., Esaote S.P.A, Hologic, Inc., Samsung Medison, and, Shimadzu Corporation.
Segment and country specific company shares, news & deals, m&a, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
The market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Install Base Data of Nuclear Medicine Machines (Country-wise break-up)
- Number of nuclear medicine units installed in various regions.
Hospital Administrators and GPO Perception Matrix
- Fast turn-around analysis to market events and trends
- Opinion about products from different companies
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals, Diagnostic Imaging Centers, Cardiac Clinics and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 PET
4.2 SPECT
5 By Applications
5.1 Cancer
5.2 Cardiovascular Disorders
5.3 Neurological disorders
6 By Geographies
6.1 USA
6.2 Europe
6.3 Asia-Pacific
6.4 Japan
6.5 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
